Life Science Analytics, March 2011, Pages: 32
AffibodyAB-Deals & Alliances ReportReport contains the company’s contact information, business summary, company details, tables, graphs and listings of the number of deals by deal category (product
Decision Resources, Inc., June 2011
-domain antibodies (dAb), Fc fusion proteins, development candidates
Bispecific, multivalent, and multimodular antibodies: Advantages, myriad formats, manufacturing challenges, development candidates
Business Insights, Feb 2007, Pages: 209
Evolution of mAbs
Drivers for innovation
The mAb business landscape
Products on the US market
Products in development
Improving mAb production systems
Cell lines
Automation
Manipulating mAb
John Wiley and Sons Ltd, Aug 2010, Pages: 632
.
1.5 Domain-Deleted Monoclonal Antibodies.
1.6 Hypervariable Domain Region Peptides.
1.7 Fv Fragments.
1.8 Minibodies.
1.9 Selective High Affinity Ligands.
1.10 Affibodies.
1.11 Other Strategies
Global Industry Analysts, Inc., Oct 2011, Pages: 749
Acquires Exclusive Rights of Immune-Stimulatory
Molecules from Amgen 98
Apitope and Merck Serono Sign Agreement for Multiple Sclerosis
Drug 99
Biovitrum and Affibody® Enter into Collaboration 99
Bayhill